Target intelligence / Profile preview

Acetolactate synthase (ALS) (ALS)

Target
ALS
Molecular classification
Enzyme, Thiamine pyrophosphate-dependent enzyme
01

Overview

Acetolactate synthase (ALS), also known as acetohydroxyacid synthase (AHAS), is a key enzyme found in plants, bacteria, and fungi that catalyzes the first step in the biosynthesis of branched-chain amino acids (BCAAs), specifically valine, leucine, and isoleucine (McCourt & Duggleby, 2006). The enzyme functions as a multimer and requires thiamine pyrophosphate (TPP), flavin adenine dinucleotide (FAD), and a divalent metal ion for its catalytic activity (Duggleby & Pang, 2000). Because humans and other mammals lack the ALS enzyme and must obtain BCAAs through their diet, it serves as an ideal target for highly selective herbicides that exhibit low mammalian toxicity (Lonhienne et al., 2018). Several major classes of herbicides, including sulfonylureas and imidazolinones, exert their effect by binding to the ALS enzyme and blocking the synthesis of essential amino acids, which leads to the cessation of plant growth and eventual death (Garcia et al., 2017). Beyond its agricultural importance, ALS is being investigated as a potential therapeutic target for antimicrobial and antifungal drugs, as it is essential for the survival of various human pathogens (McCourt & Duggleby, 2006). However, the widespread use of ALS-inhibiting herbicides has led to the rapid evolution of resistance in many weed species, primarily through point mutations in the ALS gene (Garcia et al., 2017).

Other names
Acetohydroxyacid synthaseAHASEC 2.2.1.6
02

Mechanism of action

Inhibition of the enzyme blocks the synthesis of branched-chain amino acids (valine, leucine, and isoleucine), leading to metabolic starvation and cessation of growth (Lonhienne et al., 2018).

03

Biological functions

Branched-chain amino acid biosynthesisValine biosynthesisLeucine biosynthesisIsoleucine biosynthesis
04

Disease associations

Infection
05

Safety considerations

Development of herbicide resistance in weedsPotential for cross-resistanceLow mammalian toxicity due to absence of the target enzyme in humans (Lonhienne et al., 2018)
06

Interacting drugs

Chlorsulfuron

6 more in the full profile.

07

Biomarkers

Valine levelsLeucine levelsIsoleucine levelsAlpha-ketobutyrate accumulation

Beyond the preview

Go deeper on Acetolactate synthase (ALS) (ALS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetolactate synthase (ALS) (ALS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call